Funded Tech Companies
Grey Wolf Therapeutics
Grey Wolf Therapeutics is a biopharmaceutical growth company, based in Abingdon. Venture investment and financing was provided by Pfizer Venture Investments, Oxford Science Enterprises and Earlybird Venture Capital.
Company Overview
Company Name
Grey Wolf Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Milton Park Innovation Centre 99 Park Drive, Milton Park
Abingdon, OX14 4RY
UK
Abingdon, OX14 4RY
UK
Phone
Website
Email Address
Company Background Information
Overview
Grey Wolf is a UK and Australian-based drug discovery and development company focused on developing novel immuno-oncology agents. The company was founded in 2017 by experienced industry professionals; Tom McCarthy (Executive Chairman; former President and CEO of Spinifex Pharmaceuticals), and Peter Joyce (CEO; former Project Leader at Vertex Pharmaceuticals).?
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/26/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Joyce
Co-Founder
Thomas McCarthy
Company Investors
- Pfizer Venture Investments
- Oxford Science Enterprises
- Earlybird Venture Capital
- Canaan Partners
- Andera Partners
- British Patient Capital
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs